Canadian Health Care Professionals' Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional Survey.
Canada
Chronic cough
Diagnosis
Physician survey
Treatment
Journal
Lung
ISSN: 1432-1750
Titre abrégé: Lung
Pays: United States
ID NLM: 7701875
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
04
12
2022
accepted:
01
02
2023
pubmed:
23
2
2023
medline:
3
3
2023
entrez:
22
2
2023
Statut:
ppublish
Résumé
Educational programs on chronic cough may improve patient care, but little is known about how Canadian physicians manage this common debilitating condition. We aimed to investigate Canadian physicians' perceptions, attitudes, and knowledge of chronic cough. We administered a 10-min anonymous, online, cross-sectional survey to 3321 Canadian physicians in the Leger Opinion Panel who managed adult patients with chronic cough and had been in practice for > 2 years. Between July 30 and September 22, 2021, 179 physicians (101 general practitioners [GPs] and 78 specialists [25 allergists, 28 respirologists, and 25 ear/nose/throat specialists]) completed the survey (response rate: 5.4%). In a month, GPs saw a mean of 27 patients with chronic cough, whereas specialists saw 46. About one-third of physicians appropriately identified a duration of > 8 weeks as the definition for chronic cough. Many physicians reported not using international chronic cough management guidelines. Patient referrals and care pathways varied considerably, and patients frequently experienced lost to follow-up. While physicians endorsed nasal and inhaled corticosteroids as common treatments for chronic cough, they rarely used other guideline-recommended treatments. Both GPs and specialists expressed high interest in education on chronic cough. This survey of Canadian physicians demonstrates low uptake of recent advances in chronic cough diagnosis, disease categorization, and pharmacologic management. Canadian physicians also report unfamiliarity with guideline-recommended therapies, including centrally acting neuromodulators for refractory or unexplained chronic cough. This data highlights the need for educational programs and collaborative care models on chronic cough in primary and specialist care.
Identifiants
pubmed: 36808540
doi: 10.1007/s00408-023-00604-y
pii: 10.1007/s00408-023-00604-y
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
47-55Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Satia I, Mayhew AJ, Sohel N et al (2021) Prevalence, incidence, and characteristics of chronic cough among adults from the Canadian Longitudinal Study on Aging (CLSA). ERJ Open Res 7(2):00160–02021. https://doi.org/10.1183/23120541.00160-2021
doi: 10.1183/23120541.00160-2021
pubmed: 34007841
pmcid: 8093484
Smyrnios NA, Irwin RS, Curley FJ (1995) Chronic cough with a history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest 108(4):991–997. https://doi.org/10.1378/chest.108.4.991
doi: 10.1378/chest.108.4.991
pubmed: 7555175
Dicpinigaitis PV (2006) Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest 129(1 Suppl):169S-173S. https://doi.org/10.1378/chest.129.1_suppl.169S
doi: 10.1378/chest.129.1_suppl.169S
pubmed: 16428706
Farooqi MAM, Cheng V, Wahab M, Shahid I, O’Byrne PM, Satia I (2020) Investigations and management of chronic cough: a 2020 update from the European Respiratory Society Chronic Cough Task Force. Pol Arch Intern Med 139(9):789–795. https://doi.org/10.20452/pamw.15484
doi: 10.20452/pamw.15484
Haque RA, Usmani OS (2005) Barnes PJ (2005) Chronic idiopathic cough: a discrete clinical entity? Chest 127(5):1710–1713. https://doi.org/10.1378/chest.127.5.1710
doi: 10.1378/chest.127.5.1710
pubmed: 15888850
Kaplan AG (2019) Chronic cough in adults: make the diagnosis and make a difference. Pulm Ther 5(1):11–21. https://doi.org/10.1007/s41030-019-0089-7
doi: 10.1007/s41030-019-0089-7
pubmed: 32026427
pmcid: 6966942
Morice AH, Millqvist E, Bieksiene K et al (2020) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 55(1):1901136. https://doi.org/10.1183/13993003.01136-2019
doi: 10.1183/13993003.01136-2019
pubmed: 31515408
Irwin RS, French CL, Chang AB, Altman KW, CHEST Expert Cough Panel (2018) Classification of cough as a symptom in adults and management algorithms. CHEST guideline and expert panel report. Chest 153(1):196–209. https://doi.org/10.1016/j.chest.2017.10.016
doi: 10.1016/j.chest.2017.10.016
Satia I, Wahab M, Kum E et al (2021) Chronic cough: investigations, management, current and future treatments. Can J Respir Crit Care Sleep Med 5(6):404–416. https://doi.org/10.1080/24745332.2021.1979904
doi: 10.1080/24745332.2021.1979904
Morice AH, Millqvist E, Belvisi MG et al (2014) Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J 44(5):1132–1148. https://doi.org/10.1183/09031936.00218613
doi: 10.1183/09031936.00218613
pubmed: 25142479
Hull JH, Langerman H, ul-Haq Z, Kamalati T, Lucas A, Levy ML (2021) Burden and impact of chronic cough in UK primary care: a dataset analysis. BMJ Open 11:e054832. https://doi.org/10.1136/bmjopen-2021-054832
doi: 10.1136/bmjopen-2021-054832
pubmed: 34921086
pmcid: 8685971
Meltzer EO, Zeiger RS, Dicpinigaitis P et al (2021) Prevalence and burden of chronic cough in the United States. J Allergy Clin Immunol Pract 9(11):4037-4044.e2. https://doi.org/10.1016/j.jaip.2021.07.022
doi: 10.1016/j.jaip.2021.07.022
pubmed: 34333189
Zeiger RS, Schatz M, Butler RK, Weaver JP, Bali V, Chen W (2020) Burden of specialist-diagnosed chronic cough in adults. J Allergy Clin Immunol Pract 8(5):1645–1657. https://doi.org/10.1016/j.jaip.2020.01.054
doi: 10.1016/j.jaip.2020.01.054
pubmed: 32059869
Zeiger RS, Schatz M, Hong B et al (2021) Patient-reported burden of chronic cough in a managed care organization. J Allergy Clin Immunol Pract 9(4):1624–1637. https://doi.org/10.1016/j.jaip.2020.11.018
doi: 10.1016/j.jaip.2020.11.018
pubmed: 33227523
Prenner B, Topp R, Beltyukova S, Fox C (2022) Referrals, etiology, prevalence, symptoms, and treatments of chronic cough. A survey of allergy specialists. Ann Allergy Asthma Immunol 20:22. https://doi.org/10.1016/j.anai.2022.08.993
doi: 10.1016/j.anai.2022.08.993
Dicpinigaitis PV, Birring SS, Blaiss M et al (2022) Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough. Ann Allergy Asthma Immunol. https://doi.org/10.1016/j.anai.2022.05.003
doi: 10.1016/j.anai.2022.05.003
pubmed: 35569802
Kum E, Guyatt GH, Munoz C et al (2022) Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel. ERJ Open Res 8(1):00667–02021. https://doi.org/10.1183/23120541.00667-2021
doi: 10.1183/23120541.00667-2021
pubmed: 35295233
pmcid: 8918938
Chamberlain SAF, Garrod R, Douiri A et al (2015) The impact of chronic cough: a cross-sectional European survey. Lung 193(3):401–408. https://doi.org/10.1007/x00408-015-9701-2
doi: 10.1007/x00408-015-9701-2
pubmed: 25787221
Satia I, Mayhew AJ, Sohel N et al (2022) Impact of mental health and personality traits on the incidence of chronic cough in the Canadian Longitudinal Study on Aging. ERJ Open Res 8(2):00119–02022. https://doi.org/10.1183/23120541.00119-2022
doi: 10.1183/23120541.00119-2022
pubmed: 35651367
pmcid: 9149388
Chung KF, McGarvey L, Song WJ et al (2022) Cough hypersensitivity and chronic cough. Nat Rev Dis Prim. 8(1):45. https://doi.org/10.1038/s41572-022-00370-w
doi: 10.1038/s41572-022-00370-w
pubmed: 35773287
Gowan TM, Huffman M, Weiner M et al (2021) Management of chronic cough in adult primary care: a qualitative study. Lung 199(5):563–568. https://doi.org/10.1007/s00408-021-00478-y
doi: 10.1007/s00408-021-00478-y
pubmed: 34591158
pmcid: 8481753
Puente-Maestu L, Molina-París J, Trigueros JA et al (2021) A survey of physicians’ perception of the use and effectiveness of diagnostic and therapeutic procedures in chronic cough patients. Lung 199(5):507–515. https://doi.org/10.1007/s00408-021-00475-1
doi: 10.1007/s00408-021-00475-1
pubmed: 34533587
pmcid: 8510925
Irwin RS, Boulet LP, Cloutier MM et al (1998) Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 114:133S-181S. https://doi.org/10.1378/chest.114.2_supplement.133s
doi: 10.1378/chest.114.2_supplement.133s
pubmed: 9725800
Poe RH, Israel RH, Utell MJ, Hall WJ (1982) Chronic cough: bronchoscopy or pulmonary function testing? Am Rev Respir Dis 126(1):160–162. https://doi.org/10.1164/arrd.1982.126.1.160
doi: 10.1164/arrd.1982.126.1.160
pubmed: 7091901
Poe RH, Harder RV, Israel RH, Kallay MC (1989) Chronic persistent cough. Experience in diagnosis and outcome using an anatomic diagnostic protocol. Chest 95(4):723–728. https://doi.org/10.1378/chest.95.4.723
doi: 10.1378/chest.95.4.723
pubmed: 2924600
Song WJ, Chang YS, Faruqi S et al (2016) Defining chronic cough: a systematic review of the epidemiological literature. Allergy Asthma Immunol Res 8(2):146–155. https://doi.org/10.4168/aair.2016.8.2.146
doi: 10.4168/aair.2016.8.2.146
pubmed: 26739408
Morice A, Smith JA, McGarvey L et al (2021) Eliapixant (BAY1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover pase 2a study. Eur Respir J 58(5):2004240. https://doi.org/10.1183/13993003.04240-2020
doi: 10.1183/13993003.04240-2020
pubmed: 33986030
pmcid: 8607926
McGarvey LP, Birring SS, Morice AH et al (2022) Efficacy and safety of gefapixant, a P2X
doi: 10.1016/S0140-6736(21)02348-5
pubmed: 35248186
Ryan NM, Birring SS, Gibson PG (2012) Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 380(9853):1583–1589. https://doi.org/10.1016/S0140-6736(12)60776-4
doi: 10.1016/S0140-6736(12)60776-4
pubmed: 22951084
Chamberlain Mitchell SAF, Garrod R, Clark L et al (2017) Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial. Thorax 72(2):129–136. https://doi.org/10.1136/thoraxjnl-2016-2008843
doi: 10.1136/thoraxjnl-2016-2008843
pubmed: 27682331
Leuppi JD, Guggisberg P, Koch D et al (2022) Understanding physician’s knowledge and perception of chronic cough in Switzerland. Curr Med Res Opin 38(8):1459–1466. https://doi.org/10.1080/03007995.2022.2057154
doi: 10.1080/03007995.2022.2057154
pubmed: 35369836
Gibson P, Wang G, McGarvey L et al (2016) Treatment of unexplained chronic cough: CHEST guidelines and expert panel report. Chest 149(1):27–44. https://doi.org/10.1378/chest.15-1496
doi: 10.1378/chest.15-1496
pubmed: 26426314
pmcid: 5831652
Overington JD, Huang YC, Abramson MJ et al (2014) Implementing clinical guidelines for chronic obstructive pulmonary disease: barriers and solutions. J Thorac Dis 6(11):1586–1596. https://doi.org/10.3978/j.issn.2072-1439.2014.11.25
doi: 10.3978/j.issn.2072-1439.2014.11.25
pubmed: 25478199
pmcid: 4255168
Howard M, Noppens R, Gonzalez N, Jones PM, Payne SM (2021) Seven years on from the Canadian Airway Focus Group Difficult Airway Guidelines: an observational survey. Can J Anaesth 68(9):1331–1336. https://doi.org/10.1007/s12630-021-02056-5
doi: 10.1007/s12630-021-02056-5
pubmed: 34231128
pmcid: 8259770
Fischer F, Lange K, Klose K, Greiner W, Kraemer A (2016) Barriers and strategies in guideline implementation—a scoping review. Healthcare (Basel) 4(3):36. https://doi.org/10.3390/healthcare4030036
doi: 10.3390/healthcare4030036
pubmed: 27417624
Jiang V, Marshall Brooks E, Tong ST et al (2020) Factors influencing update of changes to clinical preventive guidelines. J Am Board Fam Med 33(2):271–278. https://doi.org/10.3122/jabfm.2020.02.190146
doi: 10.3122/jabfm.2020.02.190146
pubmed: 32179610
pmcid: 7170012
Belzak L, Halverson J (2018) Evidence synthesis—the opioid crisis in Canada: a national perspective. Health Promot Chronic Dis Prev Can 38(6):224–233. https://doi.org/10.24095/hpcdp.38.6.02
doi: 10.24095/hpcdp.38.6.02
pubmed: 29911818
Mattson CL, Chowdhury F, Gilson TP (2022) Notes from the field: trends in gabapentin detection and involvement in drug overdose deaths—23 states and the District of Columbia, 2019–2020. MMWR Morb Mortal Wkly Rep 71(19):664–666. https://doi.org/10.15585/mmwr.mm7119a3
doi: 10.15585/mmwr.mm7119a3
pubmed: 35552367
pmcid: 9098248
Morice A, Dicpinigaitis P, McGarvey L, Birring SS (2021) Chronic cough: new insights and future prospects. Eur Respir Rev 30(162):210127. https://doi.org/10.1183/16000617.0127-2021
doi: 10.1183/16000617.0127-2021
pubmed: 34853095
pmcid: 9488126
Slinger C, Mehdi SB, Milan SJ et al (2019) Speech and language therapy for management of chronic cough. Cochrane Database Syst Rev 7(7):CD013067. https://doi.org/10.1002/14651858.CD013067
doi: 10.1002/14651858.CD013067
pubmed: 31335963